Correlation Between Eli Lilly and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Eli Lilly and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Chugai Pharmaceutical.
Diversification Opportunities for Eli Lilly and Chugai Pharmaceutical
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eli and Chugai is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Eli Lilly i.e., Eli Lilly and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between Eli Lilly and Chugai Pharmaceutical
Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the Chugai Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 2.45 times less risky than Chugai Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Chugai Pharmaceutical Co is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 4,980 in Chugai Pharmaceutical Co on September 1, 2024 and sell it today you would lose (346.00) from holding Chugai Pharmaceutical Co or give up 6.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Eli Lilly and vs. Chugai Pharmaceutical Co
Performance |
| Timeline |
| Eli Lilly |
| Chugai Pharmaceutical |
Eli Lilly and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and Chugai Pharmaceutical
The main advantage of trading using opposite Eli Lilly and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.| Eli Lilly vs. Crinetics Pharmaceuticals | Eli Lilly vs. Enanta Pharmaceuticals | Eli Lilly vs. Amicus Therapeutics | Eli Lilly vs. Connect Biopharma Holdings |
| Chugai Pharmaceutical vs. Sanofi ADR | Chugai Pharmaceutical vs. Bristol Myers Squibb | Chugai Pharmaceutical vs. AstraZeneca PLC ADR | Chugai Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |